General Information of the Compound
Compound ID
CP0408839
Compound Name
3-(2-aminobenzimidazol-1-yl)-1-(4-chlorophenyl)propan-1-one
    Show/Hide
Structure
Formula
C16H14ClN3O
Molecular Weight
299.761
Canonical SMILES
Nc1nc2ccccc2n1CCC(=O)c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C16H14ClN3O/c17-12-7-5-11(6-8-12)15(21)9-10-20-14-4-2-1-3-13(14)19-16(20)18/h1-8H,9-10H2,(H2,18,19)
    Show/Hide
InChIKey
HDPKIGRYBURQND-UHFFFAOYSA-N
Physicochemical Property
logP
3.5449
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
60.91
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 70693845
ChEMBL ID
CHEMBL2018276
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03645, Nucleotide-binding oligomerization domain-containing protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 16300 nM
   TI
   LI
   LO
   TS
Protein ID: PT03970, Nucleotide-binding oligomerization domain-containing protein 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS